Search Results

4 results

  1. TSRC, Tob. Sci. Res. Conf., 2021, 74, abstr. 32

    Development of recommendations of descriptive consumer-reported outcome measures (descriptive-CROM) and related definitions in tobacco and nicotine research

    WEI L.(1) on behalf of CORESTA CROM Task Force: CLERC E.(2); SHETTY M.(3); CHREA C.(2); PRASAD K.(3); SARKAR M.(1)
    (1) Altria Client Services LLC, Richmond, VA, USA; (2) Philip Morris International, Neuchâtel, Switzerland; (3) British American Tobacco, Southampton, UK
    Background: The Consumer Reported Outcome Measures (CROM) Consortium Task Force (TF), consisting of academic researchers and members from various tobacco companies, was formed within the Cooperation Centre for Scientific Research Relative to Tobacco...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STW 08

    Modeling the impact of a tobacco product with a modified risk claim on population health: the role of sensitivity analyses

    MUHAMMAD-KAH R.; PITHAWALLA Y.B.; BLACK R.; WEI L.; HANNEL T.; SARKAR M.
    Altria Client Services LLC, Richmond, VA 23219, U.S.A.
    Computational models can be used to assess the population health impact of a modified risk claim on a tobacco product, while taking into account tobacco users and non-tobacco users. We present here a case study of a smokeless tobacco (ST) product...
  3. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 37

    Assessing the population health impact of authorizing the marketing of a smokeless tobacco product with a proposed modified risk claim

    MUHAMMAD-KAH R.(1); PITHAWALLA Y.B.(1); JONES M.(1); WEI L.(1); BRYAN T.(1); BLACK R.(1); BOONE E.(2); SARKAR M.(1)
    (1) Altria Client Services LLC, Richmond, VA, U.S.A.; (2) Virginia Commonwealth University, Richmond, VA, U.S.A.
    Computational models can be used to predict population effects following the market authorization of a tobacco product with a modified risk claim. Using best modeling practices we developed and validated a population model. Since moist smokeless...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 57

    Assessing the potential population health impact of market authorization of e-cigarettes in the U.S.

    MUHAMMAD-KAH R.; PITHAWALLA Y.B.; HANNEL T.; WEI L.; BLACK R.; BRYAN T.; GOGOVA M.
    Altria Client Services LLC, Richmond, VA, U.S.A.
    When evaluating a Premarket Tobacco Product Application (PMTA) or Modified Risk Tobacco Product Application (MRTPA), the Food and Drug Administration (FDA) employs a Population Health Standard, which requires evaluation of risk and benefit to the...